Перегляд ФПО. Кафедра терапевтичних дисциплін та сімейної медицини за темою "chronic kidney disease"

Відображені елементи 1-2 з 2

Safety and efficacy of initiation SGLT in heart failure with a reduced left ventricular ejection fraction and chronic kidney disease on top of standard therapy with ARNI or ACE-i

Obertynska, O.; Rasputina, L. (European Heart Journal, 2024)

Quadruple therapy remains underused in cases of heart failure with a reduced ejection fraction (HFrEF). Among eligible patients most of them take ACE-i/ARB and B-blockers, less MRAs and ARNI. There are many questions of ...
The safety of in-hospital initiation of SGLT2 inhibitor with MRA therapy in patients hospitalized for heart failure with a reduced left ventricular ejection fraction and chronic kidney disease

Obertynska, O.; Rasputina, L. (European Heart Journal, 2024)

Deferring in-hospital initiation of guideline-recommended medications in HFrEF has a few chances they will be initiated ambulatory, especially in the case of coexisting HFrEF and chronic kidney disease (CKD). The aim was ...

Пошук